COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,100 Articles (22,658 medRxiv, 8,442 bioRxiv)

Most recent first Previous |  Page 320: Articles 3191-3200  | Next

Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model Sera
Mühlemann, B., Wilks, S. H., Baracco, L., Bekliz, M., Carreno, J. M., Corman, V. M., Davis-Gardner, M. E., Dejnirattisai, W., Diamond, M., Doueck, D., Drosten, C., Eckerle, I., Edara, V. V., Ellis, M., Fouchier, R. A., Frieman, M., Godbole, S., Haagmans, B., Halfmann, P., Henry, A. R., Jones, T. C., Katzelnick, L., Kawaoka, Y., Kimpel, J., Krammer, F., Lai, L., Liu, C., Lusvarghi, S., Meyer, B., Mongkolsapaya, J., Montefiori, D., Mykytyn, A. Z., Netzl, A., Pollett, S., Rössler, A., Screaton, G., Shen, X., Sigal, A., Simon, V., Subramanian, R., Supasa, P., Suthar, M., Tureli, S., Wang, W., Weiss, C. D., Smith, D. J.
10.1101/2023.09.27.559689 — Posted: 2023-09-27
p38-MAPK is prerequisite for the synthesis of SARS-CoV-2 protein
Mittal, P., Khandelwal, N., Chander, Y., Verma, A., Kumar, R., Putatunda, C., Barua, S., Gulati, B. R., Kumar, N.
10.1101/2023.09.27.559660 — Posted: 2023-09-27
survInTime - Exploring surveillance methods and data analysis on Brazilian respiratory syndrome dataset and community mobility changes
Martins, Y. C., Francisco, R. d. S.
10.1101/2023.09.26.559599 — Posted: 2023-09-27
Development of a mutant aerosolized ACE2 that neutralizes SARS-CoV-2 in vivo
Kober, D. L., Caballero Van Dyke, M. C., Eitson, J. L. E. L., Rosenbaum, D., Schoggins, J. W.
10.1101/2023.09.26.559550 — Posted: 2023-09-27
SARS-CoV-2 Omicron BA.2.86: less neutralization evasion compared to XBB sub-variants
An, Y., Zhou, X., Tao, L., Xie, H., Li, D., Wang, R., Hu, H., Xu, Z., Dai, L., Xu, K., Gao, G. F.
10.1101/2023.09.26.559580 — Posted: 2023-09-27
Research ethics review during the COVID-19 pandemic An international study
Salamanca-Buentello, F., Katz, R., Silva, D. S., Upshur, R. E. G., Smith, M. J.
10.1101/2023.09.24.23296056 — Posted: 2023-09-26
Comparative performance of COVID-19 test methods in healthcare workers during the omicron wave
Tornberg, E. C., Tomlinson, A., Oshiro, N. T. T., Derfalie, E., Curlin, M.
10.1101/2023.09.25.23296099 — Posted: 2023-09-26
Determinants of health as predictors for differential antibody responses following SARS-CoV-2 primary and booster vaccination in an at-risk, longitudinal cohort
Echeverri Tribin, F., Williams, E., Testamarck, V., Carreno, J. M., Bielak, D., Yellin, T., Krammer, F., Hoffer, M., Pallikkuth, S., Pahwa, S.
10.1101/2023.09.25.23296114 — Posted: 2023-09-26
Near-term forecasting of Covid-19 cases and hospitalisations in Aotearoa New Zealand
Plank, M. J., Watson, L. M., Maclaren, O. J.
10.1101/2023.09.25.23296118 — Posted: 2023-09-26
Evaluation of computer vision syndrome in the sample of students from the College of Medicine/University of Kerbala result of online learning with the isolation of COVID-19
AbuRagheif, m. h.
10.1101/2023.09.25.23295828 — Posted: 2023-09-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).